- In July 2024, Cognizant and Yseop have partnered to scale medical writing using Generative Artificial Intelligence (AI). This collaboration aims to enhance the efficiency and accuracy of medical writing by automating the creation of clinical, regulatory, and scientific documents. By integrating AI into the medical writing process, the partnership will streamline the generation of high-quality, compliant content, reducing the time required for document preparation. The benefit of this partnership is the ability to speed up drug development and regulatory approval processes while ensuring precision and consistency in the documentation, ultimately improving the overall productivity of the healthcare industry
